• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

B 细胞非霍奇金淋巴瘤中特定亚型和共同发生的遗传改变。

Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma.

机构信息

Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.

Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE.

出版信息

Haematologica. 2022 Mar 1;107(3):690-701. doi: 10.3324/haematol.2020.274258.

DOI:10.3324/haematol.2020.274258
PMID:33792219
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8883549/
Abstract

B-cell non-Hodgkin lymphoma (B-NHL) encompasses multiple clinically and phenotypically distinct subtypes of malignancy with unique molecular etiologies. Common subtypes of B-NHL, such as diffuse large B-cell lymphoma, have been comprehensively interrogated at the genomic level, but rarer subtypes, such as mantle cell lymphoma, remain less extensively characterized. Furthermore, multiple B-NHL subtypes have thus far not been comprehensively compared using the same methodology to identify conserved or subtype-specific patterns of genomic alterations. Here, we employed a large targeted hybrid-capture sequencing approach encompassing 380 genes to interrogate the genomic landscapes of 685 B-NHL tumors at high depth, including diffuse large B-cell lymphoma, mantle cell lymphoma, follicular lymphoma, and Burkitt lymphoma. We identified conserved hallmarks of B-NHL that were deregulated in the majority of tumors from each subtype, including frequent genetic deregulation of the ubiquitin proteasome system. In addition, we identified subtype-specific patterns of genetic alterations, including clusters of co-occurring mutations and DNA copy number alterations. The cumulative burden of mutations within a single cluster were more discriminatory of B-NHL subtypes than individual mutations, implicating likely patterns of genetic cooperation that contribute to disease etiology. We therefore provide the first cross-sectional analysis of mutations and DNA copy number alterations across major B-NHL subtypes and a framework of co-occurring genetic alterations that deregulate genetic hallmarks and likely cooperate in lymphomagenesis.

摘要

B 细胞非霍奇金淋巴瘤(B-NHL)包含多种临床上和表型上不同的恶性肿瘤亚型,具有独特的分子病因。B-NHL 的常见亚型,如弥漫性大 B 细胞淋巴瘤,在基因组水平上已经得到了全面研究,但更罕见的亚型,如套细胞淋巴瘤,特征仍不够明确。此外,迄今为止,尚未使用相同的方法对多种 B-NHL 亚型进行全面比较,以确定基因组改变的保守或亚型特异性模式。在这里,我们采用了一种大型靶向杂交捕获测序方法,涵盖了 380 个基因,以高深度检测了 685 例 B-NHL 肿瘤的基因组图谱,包括弥漫性大 B 细胞淋巴瘤、套细胞淋巴瘤、滤泡性淋巴瘤和伯基特淋巴瘤。我们确定了 B-NHL 的保守特征,这些特征在每种亚型的大多数肿瘤中都存在失调,包括泛素蛋白酶体系统的频繁遗传失调。此外,我们还确定了遗传改变的亚型特异性模式,包括共同发生的突变和 DNA 拷贝数改变簇。单个簇内突变的累积负担比单个突变更能区分 B-NHL 亚型,提示可能存在遗传合作模式,这些模式可能导致疾病的病因。因此,我们提供了 across major B-NHL subtypes 的突变和 DNA 拷贝数改变的首次横向分析,以及调节遗传特征并可能在淋巴瘤发生中合作的共同发生遗传改变的框架。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f02/8883549/e3263ba7c9a5/107690.fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f02/8883549/016cd8673c05/107690.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f02/8883549/eace5811097e/107690.fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f02/8883549/8de388d77cb6/107690.fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f02/8883549/1dbf7dbfa1f7/107690.fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f02/8883549/e59d5b2a37a2/107690.fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f02/8883549/e3263ba7c9a5/107690.fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f02/8883549/016cd8673c05/107690.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f02/8883549/eace5811097e/107690.fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f02/8883549/8de388d77cb6/107690.fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f02/8883549/1dbf7dbfa1f7/107690.fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f02/8883549/e59d5b2a37a2/107690.fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f02/8883549/e3263ba7c9a5/107690.fig6.jpg

相似文献

1
Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma.B 细胞非霍奇金淋巴瘤中特定亚型和共同发生的遗传改变。
Haematologica. 2022 Mar 1;107(3):690-701. doi: 10.3324/haematol.2020.274258.
2
[Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].恶性淋巴瘤基因组拷贝数改变分析及其诊断应用
Gan To Kagaku Ryoho. 2007 Jul;34(7):975-82.
3
Cause-specific mortality among Medicare beneficiaries with newly diagnosed non-Hodgkin lymphoma subtypes.医疗保险受益人群中患有新诊断非霍奇金淋巴瘤亚型的患者的特定病因死亡率。
Cancer. 2019 Apr 1;125(7):1101-1112. doi: 10.1002/cncr.31821. Epub 2018 Dec 11.
4
Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project.国际淋巴瘤流行病学联盟(InterLymph)非霍奇金淋巴瘤亚型项目的原理与设计
J Natl Cancer Inst Monogr. 2014 Aug;2014(48):1-14. doi: 10.1093/jncimonographs/lgu005.
5
Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011.美国非霍奇金淋巴瘤亚型分布、地理人口统计学模式和生存情况:1998 年至 2011 年国家癌症数据库的纵向分析。
Am J Hematol. 2015 Sep;90(9):790-5. doi: 10.1002/ajh.24086. Epub 2015 Jul 27.
6
Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.利妥昔单抗:用于非霍奇金淋巴瘤和慢性淋巴细胞白血病的综述
Drugs. 2003;63(8):803-43. doi: 10.2165/00003495-200363080-00005.
7
Pathogenesis of non-Hodgkin's lymphoma.非霍奇金淋巴瘤的发病机制。
J Clin Oncol. 2011 May 10;29(14):1803-11. doi: 10.1200/JCO.2010.33.3252. Epub 2011 Apr 11.
8
Alterations of microRNA and microRNA-regulated messenger RNA expression in germinal center B-cell lymphomas determined by integrative sequencing analysis.通过整合测序分析确定生发中心B细胞淋巴瘤中微小RNA及微小RNA调控的信使核糖核酸表达的改变
Haematologica. 2016 Nov;101(11):1380-1389. doi: 10.3324/haematol.2016.143891. Epub 2016 Jul 6.
9
Frequent mutation of the 5' noncoding region of the BCL-6 gene in acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas.获得性免疫缺陷综合征相关非霍奇金淋巴瘤中BCL-6基因5'非编码区的频繁突变
Blood. 1997 May 15;89(10):3755-62.
10
B-Cell NHL Subtype Risk Associated with Autoimmune Conditions and PRS.B 细胞 NHL 亚型与自身免疫性疾病和 PRS 相关。
Cancer Epidemiol Biomarkers Prev. 2022 May 4;31(5):1103-1110. doi: 10.1158/1055-9965.EPI-21-0875.

引用本文的文献

1
Cyclin D1 overexpression induces replication stress and microhomology-mediated end-joining dependence in mantle cell lymphoma.细胞周期蛋白D1过表达在套细胞淋巴瘤中诱导复制应激和微同源性介导的末端连接依赖性。
J Clin Invest. 2025 Jul 3;135(17). doi: 10.1172/JCI193006. eCollection 2025 Sep 2.
2
Trends of Non-Hodgkin Lymphoma Incidence Among Adults in the United States From 2000 to 2020.2000年至2020年美国成年人非霍奇金淋巴瘤发病率趋势
Cancer Rep (Hoboken). 2025 Jul;8(7):e70269. doi: 10.1002/cnr2.70269.
3
Correlations Between Immunophenotypic Markers and Clinical Progression in Romanian Patients Diagnosed with Diffuse Large B-Cell Lymphoma.

本文引用的文献

1
Histone H1 loss drives lymphoma by disrupting 3D chromatin architecture.组蛋白 H1 缺失通过破坏 3D 染色质结构驱动淋巴瘤。
Nature. 2021 Jan;589(7841):299-305. doi: 10.1038/s41586-020-3017-y. Epub 2020 Dec 9.
2
Frequent mutations in the amino-terminal domain of BCL7A impair its tumor suppressor role in DLBCL.BCL7A 氨基末端结构域的频发突变使其丧失在 DLBCL 中的肿瘤抑制作用。
Leukemia. 2020 Oct;34(10):2722-2735. doi: 10.1038/s41375-020-0919-5. Epub 2020 Jun 24.
3
UBR5 HECT domain mutations identified in mantle cell lymphoma control maturation of B cells.
罗马尼亚弥漫性大B细胞淋巴瘤患者免疫表型标志物与临床进展的相关性
Medicina (Kaunas). 2025 May 22;61(6):948. doi: 10.3390/medicina61060948.
4
Genomic signatures in plasma circulating tumor DNA reveal treatment response and prognostic insights in mantel cell lymphoma.血浆循环肿瘤DNA中的基因组特征揭示了套细胞淋巴瘤的治疗反应和预后情况。
Cancer Cell Int. 2025 May 3;25(1):172. doi: 10.1186/s12935-025-03789-9.
5
Predictive biomarkers and molecular subtypes in DLBCL: insights from PCD gene expression and machine learning.弥漫性大B细胞淋巴瘤中的预测性生物标志物和分子亚型:来自PCD基因表达和机器学习的见解
Discov Oncol. 2025 Apr 16;16(1):542. doi: 10.1007/s12672-025-02349-x.
6
The art of war: using genetic insights to understand and harness radiation sensitivity in hematologic malignancies.战争的艺术:利用遗传学见解来理解和利用血液系统恶性肿瘤中的辐射敏感性。
Front Oncol. 2025 Mar 21;14:1478078. doi: 10.3389/fonc.2024.1478078. eCollection 2024.
7
Blunted CD40-responsive enhancer activation in CREBBP-mutant lymphomas can be restored by enforced CD4 T-cell engagement.在CREBBP突变的淋巴瘤中,通过强制CD4 T细胞参与,可以恢复钝性CD40反应性增强子的激活。
Blood. 2025 Jul 10;146(2):191-205. doi: 10.1182/blood.2024026664.
8
High-grade B-cell lymphoma not otherwise specified, with diffuse large B-cell lymphoma gene expression signatures: Genomic analysis and potential therapeutics.未另行指定的高级别B细胞淋巴瘤,具有弥漫性大B细胞淋巴瘤基因表达特征:基因组分析与潜在治疗方法
Am J Hematol. 2025 Jan;100(1):10-22. doi: 10.1002/ajh.27513. Epub 2024 Nov 16.
9
Multi-omics profiling of longitudinal samples reveals early genomic changes in follicular lymphoma.多组学纵向样本分析揭示滤泡性淋巴瘤早期的基因组变化。
Blood Cancer J. 2024 Aug 27;14(1):147. doi: 10.1038/s41408-024-01124-5.
10
IRF8-mutant B cell lymphoma evades immunity through a CD74-dependent deregulation of antigen processing and presentation in MHCII complexes.IRF8 突变型 B 细胞淋巴瘤通过 CD74 依赖性的 MHCII 复合物中抗原加工和呈递的失调来逃避免疫。
Sci Adv. 2024 Jul 12;10(28):eadk2091. doi: 10.1126/sciadv.adk2091.
UBR5 HECT 结构域突变可调控套细胞淋巴瘤中 B 细胞的成熟。
Blood. 2020 Jul 16;136(3):299-312. doi: 10.1182/blood.2019002102.
4
A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications.具有治疗意义的弥漫性大 B 细胞淋巴瘤遗传亚型的概率分类工具。
Cancer Cell. 2020 Apr 13;37(4):551-568.e14. doi: 10.1016/j.ccell.2020.03.015.
5
Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report.弥漫性大 B 细胞淋巴瘤的靶向测序、分子亚型与结局:血液系统恶性肿瘤研究网络报告
Blood. 2020 May 14;135(20):1759-1771. doi: 10.1182/blood.2019003535.
6
Targetable genetic alterations of () drive immunoglobulin expression in diffuse large B cell lymphoma.() 中可靶向的基因改变驱动弥漫性大 B 细胞淋巴瘤中的免疫球蛋白表达。
Sci Transl Med. 2019 Jun 19;11(497). doi: 10.1126/scitranslmed.aav5599.
7
Emerging epigenetic-modulating therapies in lymphoma.淋巴瘤中新兴的表观遗传学调节疗法。
Nat Rev Clin Oncol. 2019 Aug;16(8):494-507. doi: 10.1038/s41571-019-0190-8.
8
Follicular lymphoma-associated mutations in vacuolar ATPase ATP6V1B2 activate autophagic flux and mTOR.滤泡性淋巴瘤相关的液泡型 ATP 酶 ATP6V1B2 突变激活自噬流和 mTOR。
J Clin Invest. 2019 Mar 4;129(4):1626-1640. doi: 10.1172/JCI98288.
9
BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines.BH3 模拟药物:为新型癌症药物开辟道路。
Cancer Cell. 2018 Dec 10;34(6):879-891. doi: 10.1016/j.ccell.2018.11.004.
10
MiR-361-3p regulates ERK1/2-induced EMT via DUSP2 mRNA degradation in pancreatic ductal adenocarcinoma.miR-361-3p 通过降解 DUSP2 mRNA 调控 ERK1/2 诱导的 EMT 进程在胰腺导管腺癌中。
Cell Death Dis. 2018 Jul 24;9(8):807. doi: 10.1038/s41419-018-0839-8.